Olanzapine Accord

Olanzapine, the active ingredient in Olanzapine Accord, is an atypical antipsychotic presented as a tablet for oral use. It is used to manage symptoms of schizophrenia and bipolar disorder in adults.

GNH USA supplies Olanzapine Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olanzapine Accord acts on dopamine and serotonin pathways to treat serious mental health conditions. - Schizophrenia: Reduces hallucinations, delusions and thought disorder. - Bipolar I disorder: Controls manic episodes and stabilises mood. - Schizoaffective disorder: Alleviates both psychotic and mood symptoms.

Olanzapine may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects: - Weight gain - Sedation - Dry mouth - Constipation - Increased appetite - Dizziness

Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Tardive dyskinesia - Severe hyperglycaemia - Agranulocytosis - Seizures - Myocardial infarction

Olanzate  ");

"  "  """  " """ " "  ""  """ " ""  "...  ""  " """  ""  "" "  "  "" " " "  "" "  " "" "" " " 

"  " " "" ...